Font Size: a A A

Establish Of Abnormal Savda Disease Carring Hepaticcarsinoma Rat Model And Cell Cycle Regulation Of Gene Expression

Posted on:2015-04-30Degree:MasterType:Thesis
Country:ChinaCandidate:M M M M T Y M YiFull Text:PDF
GTID:2284330434965969Subject:Biochemistry and Molecular Biology
Abstract/Summary:PDF Full Text Request
Objective:To establish an abnormal savda disease carrying hepatocellular carci noma animal model according to Uyghur traditional medicine, investigate the impor-tant role and significance of STAT3, Cyclin D1, p21and p53gene during the pr-ogress of originating and developing of abnormal savda disease carrying hepatocell-ular carcinoma. Method:According to the theory of Uyghur traditional medicine, male wistar rats were fed with cold-natured diet under cool dry environment, stimu-lated with chronic and interrupted electric foot shocks, enforced swimming and co-ntrolled movement to establish abnormal savda syndrome rat model in Uyghur med-icine in three weeks, DEN induced20weeks with further to establish abnormal savda disease earring hepatocellular carsinoma model. Observe the morphological ch-anges of hepatic tissue by using of the microscope respectively. Application of tra-nscriptase-polymerase chain reaction(RT-PCR), immunohistochemistry and western-blot were used to detect the expression level of each group liver tissue STAT3, Cyclin D1, p21and p53genes. Result:cancer rate of abnormal savda disease carr-ying hepatocellular carcinoma model group and cancer cell atypia significantly high-er than hepatoc-ellular carcinoma control group; RT-PCR results showed that the expression of STAT3, Cyclin D1, p21and p53gene in abnormal savda disease car-rying hepatocellular carcinoma model group was higher than the normal control gr-oup and compared with the hepatocellular carcinoma control group also increased significantly,immunohistochemistry and western-blot showed that compared with the hepatocellular carcinoma control group and normal control group the expression of STAT3, Cyclin D1, p21and p53in abnormal savda carrying hepatocellular carcin -oma model group was increased. Conclusion:abnormal savda hilit was the acceler-ative factor in the process of establishing abnormal savda disease carring hepatocel-lular carcinoma model. Illustrates the abnormal savda hilit may through influencing STAT3, Cyclin D1, p21and p53gene of hepatocellular carcinoma, promote the occurrence and development of abnormal savda carring hepatocellular carcinoma.
Keywords/Search Tags:abnormal savda, hepatocellular carcinoma Syndrome animal model, STAT3, Cyclin D1, p21, p53
PDF Full Text Request
Related items